Search

Binh X. Tran

Examiner (ID: 16975, Phone: (571)272-1469 , Office: P/1713 )

Most Active Art Unit
1713
Art Unit(s)
1792, 1713, 1765
Total Applications
1670
Issued Applications
1300
Pending Applications
119
Abandoned Applications
268

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16367406 [patent_doc_number] => 10799138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-13 [patent_title] => Method of administering sotalol IV/switch [patent_app_type] => utility [patent_app_number] => 16/376706 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 7453 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376706 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/376706
Method of administering sotalol IV/switch Apr 4, 2019 Issued
Array ( [id] => 15290411 [patent_doc_number] => 20190388341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS [patent_app_type] => utility [patent_app_number] => 16/372177 [patent_app_country] => US [patent_app_date] => 2019-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372177 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/372177
CHEWABLE GEL DOSAGE FORM AND ASSOCIATED METHODS Mar 31, 2019 Abandoned
Array ( [id] => 15144935 [patent_doc_number] => 20190350945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-21 [patent_title] => USES OF OXYGENATED CHOLESTEROL SULFATES (OCS) [patent_app_type] => utility [patent_app_number] => 16/368553 [patent_app_country] => US [patent_app_date] => 2019-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21484 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368553 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/368553
Uses of oxygenated cholesterol sulfates (OCS) Mar 27, 2019 Issued
Array ( [id] => 15206045 [patent_doc_number] => 20190365709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy [patent_app_type] => utility [patent_app_number] => 16/348630 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11418 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16348630 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/348630
Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy Mar 20, 2019 Abandoned
Array ( [id] => 15524605 [patent_doc_number] => 20200054608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA [patent_app_type] => utility [patent_app_number] => 16/361085 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361085 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/361085
ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA Mar 20, 2019 Abandoned
Array ( [id] => 16688261 [patent_doc_number] => 20210070737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => ANTIVIRAL COMPOUNDS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/981346 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981346 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/981346
Antiviral compounds and use thereof Mar 17, 2019 Issued
Array ( [id] => 14531525 [patent_doc_number] => 20190201383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-04 [patent_title] => Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts [patent_app_type] => utility [patent_app_number] => 16/297006 [patent_app_country] => US [patent_app_date] => 2019-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16297006 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/297006
Apparatus and Methods for Preventing or Treating Failure of Hemodialysis Vascular Access and Other Vascular Grafts Mar 7, 2019 Abandoned
Array ( [id] => 14497741 [patent_doc_number] => 20190192525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => APILIMOD COMPOSITIONS AND METHODS FOR USING SAME [patent_app_type] => utility [patent_app_number] => 16/289963 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289963 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289963
APILIMOD COMPOSITIONS AND METHODS FOR USING SAME Feb 28, 2019 Abandoned
Array ( [id] => 16555685 [patent_doc_number] => 20210000833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => INHIBITION OF NSMASE FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION [patent_app_type] => utility [patent_app_number] => 16/977309 [patent_app_country] => US [patent_app_date] => 2019-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977309 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/977309
Inhibition of nSMase for the treatment of human immunodeficiency virus infection Feb 28, 2019 Issued
Array ( [id] => 14497619 [patent_doc_number] => 20190192464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS [patent_app_type] => utility [patent_app_number] => 16/289214 [patent_app_country] => US [patent_app_date] => 2019-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289214 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/289214
BRANCHED CHAIN FATTY ACIDS FOR PREVENTION OR TREATMENT OF GASTROINTESTINAL DISORDERS Feb 27, 2019 Abandoned
Array ( [id] => 15813773 [patent_doc_number] => 10632043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-28 [patent_title] => Premix formulation for parenteral use and packaging thereof [patent_app_type] => utility [patent_app_number] => 16/285527 [patent_app_country] => US [patent_app_date] => 2019-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6920 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285527 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/285527
Premix formulation for parenteral use and packaging thereof Feb 25, 2019 Issued
Array ( [id] => 14464481 [patent_doc_number] => 20190183880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => METHOD OF INHIBITING MUTANT C-KIT [patent_app_type] => utility [patent_app_number] => 16/283190 [patent_app_country] => US [patent_app_date] => 2019-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7836 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283190 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283190
Method of inhibiting mutant C-KIT Feb 21, 2019 Issued
Array ( [id] => 16761000 [patent_doc_number] => 20210106581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => Treatment Of Liver Diseases [patent_app_type] => utility [patent_app_number] => 16/970543 [patent_app_country] => US [patent_app_date] => 2019-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970543
Treatment Of Liver Diseases Feb 18, 2019 Abandoned
Array ( [id] => 16640788 [patent_doc_number] => 10918609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-16 [patent_title] => Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient [patent_app_type] => utility [patent_app_number] => 16/274478 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8687 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274478 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274478
Pharmaceutical composition for preventing or treating arthritis or inflammatory disease containing 2-methoxy-4-(3-(4-methoxyphenyl)propyl-1-en-1-yl)phenol as active ingredient Feb 12, 2019 Issued
Array ( [id] => 16619913 [patent_doc_number] => 20210038566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-11 [patent_title] => USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION [patent_app_type] => utility [patent_app_number] => 16/967752 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967752 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/967752
USE OF MODULATORS OF NEET PROTEINS FOR THE TREATMENT OF INFECTION Feb 7, 2019 Abandoned
Array ( [id] => 14578297 [patent_doc_number] => 20190216757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Methods for Cancer and Immunotherapy Using Prodrugs of Glutamine Analogs [patent_app_type] => utility [patent_app_number] => 16/262476 [patent_app_country] => US [patent_app_date] => 2019-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47834 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16262476 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/262476
Methods for cancer and immunotherapy using prodrugs of glutamine analogs Jan 29, 2019 Issued
Array ( [id] => 14336925 [patent_doc_number] => 20190150435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/253327 [patent_app_country] => US [patent_app_date] => 2019-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2102 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16253327 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/253327
MIXTURES OF SABADILLA ALKALOIDS AND PYRETHRUM AND USES THEREOF Jan 21, 2019 Abandoned
Array ( [id] => 16197414 [patent_doc_number] => 10722550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-28 [patent_title] => Compositions and methods for the treatment of fungal infections [patent_app_type] => utility [patent_app_number] => 16/250612 [patent_app_country] => US [patent_app_date] => 2019-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 6465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16250612 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/250612
Compositions and methods for the treatment of fungal infections Jan 16, 2019 Issued
Array ( [id] => 15510339 [patent_doc_number] => 10561736 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-02-18 [patent_title] => Apoptosis inhibitor formulations for prevention of hearing loss [patent_app_type] => utility [patent_app_number] => 16/243892 [patent_app_country] => US [patent_app_date] => 2019-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 16878 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/243892
Apoptosis inhibitor formulations for prevention of hearing loss Jan 8, 2019 Issued
Array ( [id] => 17844897 [patent_doc_number] => 11434249 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-09-06 [patent_title] => ASK1 inhibitor compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 16/958053 [patent_app_country] => US [patent_app_date] => 2018-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42691 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958053 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/958053
ASK1 inhibitor compounds and uses thereof Dec 30, 2018 Issued
Menu